The overall goal of this Technical Core is to provide support to the other projects in the Program, where there is special expertise/capability or where establishing a core facility is particularly efficient and cost effective. The support will be in: *quantification of photosensitizer concentration in tissues ex vivo, *confocal fluorescence microscopy of tissues and optical phantoms, *optical instrumentation for light delivery and light/photosensitizer dosimetry, *optical calibrations and provisions of well-characterized optical phantoms, *maintenance of an Internet hub for image/data storage and communication between laboratories. Procedures such as photosensitizer quantification and confocal fluorescence microscopy are appropriately handled within a core facility because of the ability to establish proper quality control and, hence, to provide accurate and reliable results in a timely manner. All projects will utilize these services. Optical instrumentation plays a key role in most of the projects, particularly the clinical studies, and the Core will enable instruments to be tailored to the specific needs of each project, rather than relying on either the limited available (and expensive) commercial equipment or having each laboratory construct its own with limited expertise and equipment to do so. Similarly, the calibration procedures and optical phantoms which will be provided through the core will ensure consistency between the projects. The provisions of an Internet hub will maximize communication between the projects and ensure that data generated within the Core will be disseminated rapidly and efficiently. While the primary purpose of the Technical Core is to provide essential support to the other projects, the developmental work required will be productive in its won right, especially in the areas of optical instrumentation and fluorescence analysis of tissues.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA043892-13
Application #
6563821
Study Section
Project Start
2002-01-01
Project End
2002-12-31
Budget Start
Budget End
Support Year
13
Fiscal Year
2002
Total Cost
$228,401
Indirect Cost
Name
Healthone Alliance
Department
Type
DUNS #
098407869
City
Denver
State
CO
Country
United States
Zip Code
80203
Wang, Luo-Wei; Huang, Zheng; Lin, Han et al. (2013) Effect of Photofrin-mediated photocytotoxicity on a panel of human pancreatic cancer cells. Photodiagnosis Photodyn Ther 10:244-251
Lei, Tim C; Pendyala, Srinivas; Scherrer, Larry et al. (2013) Optical profiles of cathode ray tube and liquid crystal display monitors: implication in cutaneous phototoxicity in photodynamic therapy. Appl Opt 52:2711-7
Weston, Mark A; Patterson, Michael S (2011) Calculation of singlet oxygen dose using explicit and implicit dose metrics during benzoporphyrin derivative monoacid ring A (BPD-MA)-PDT in vitro and correlation with MLL cell survival. Photochem Photobiol 87:1129-37
Santra, Manoranjan; Zheng, Xuguang; Roberts, Cindi et al. (2010) Single doublecortin gene therapy significantly reduces glioma tumor volume. J Neurosci Res 88:304-14
Singh, Gurmit; Alqawi, Omar; Espiritu, Myrna (2010) Metronomic PDT and cell death pathways. Methods Mol Biol 635:65-78
Zheng, Xuguang; Jiang, Feng; Katakowski, Mark et al. (2009) ADAM17 promotes breast cancer cell malignant phenotype through EGFR-PI3K-AKT activation. Cancer Biol Ther 8:1045-54
Hong, Xin; Jiang, Feng; Kalkanis, Steven N et al. (2009) Intracellular free calcium mediates glioma cell detachment and cytotoxicity after photodynamic therapy. Lasers Med Sci 24:777-86
Santra, Manoranjan; Santra, Sutapa; Roberts, Cindi et al. (2009) Doublecortin induces mitotic microtubule catastrophe and inhibits glioma cell invasion. J Neurochem 108:231-45
Gullo, Francesca; Maffezzoli, Andrea; Dossi, Elena et al. (2009) Short-latency cross- and autocorrelation identify clusters of interacting cortical neurons recorded from multi-electrode array. J Neurosci Methods 181:186-98
Szalad, Alexandra; Katakowski, Mark; Zheng, Xuguang et al. (2009) Transcription factor Sp1 induces ADAM17 and contributes to tumor cell invasiveness under hypoxia. J Exp Clin Cancer Res 28:129

Showing the most recent 10 out of 81 publications